Production (Stage)
Johnson & Johnson
JNJ
$152.94
$0.330.22%
NYSE
| 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 89.33B | 88.82B | 87.70B | 86.58B | 85.65B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 89.33B | 88.82B | 87.70B | 86.58B | 85.65B |
| Cost of Revenue | 27.78B | 27.04B | 26.64B | 26.27B | 25.86B |
| Gross Profit | 61.55B | 61.79B | 61.05B | 60.31B | 59.79B |
| SG&A Expenses | 21.91B | 21.95B | 21.29B | 21.18B | 20.77B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.60B | 66.22B | 64.35B | 62.36B | 61.80B |
| Operating Income | 22.73B | 22.60B | 23.35B | 24.22B | 23.85B |
| Income Before Tax | 26.60B | 16.69B | 17.63B | 19.51B | 20.06B |
| Income Tax Expenses | 4.79B | 2.62B | 2.86B | 3.12B | 2.99B |
| Earnings from Continuing Operations | 21.81K | 14.07K | 14.77K | 16.38K | 17.07K |
| Earnings from Discontinued Operations | -- | -- | -83.00M | 21.64B | 21.40B |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.81B | 14.07B | 14.68B | 38.02B | 38.48B |
| EBIT | 22.73B | 22.60B | 23.35B | 24.22B | 23.85B |
| EBITDA | 30.03B | 29.94B | 30.25B | 31.11B | 30.88B |
| EPS Basic | 9.05 | 5.83 | 5.88 | 15.08 | 15.11 |
| Normalized Basic EPS | 6.30 | 6.23 | 6.41 | 6.49 | 6.24 |
| EPS Diluted | 8.99 | 5.79 | 5.84 | 14.94 | 14.97 |
| Normalized Diluted EPS | 6.26 | 6.19 | 6.36 | 6.44 | 6.19 |
| Average Basic Shares Outstanding | 9.65B | 9.65B | 9.99B | 10.10B | 10.30B |
| Average Diluted Shares Outstanding | 9.70B | 9.71B | 10.05B | 10.17B | 10.37B |
| Dividend Per Share | 4.96 | 4.91 | 4.86 | 4.81 | 4.76 |
| Payout Ratio | 54.76% | 84.05% | 79.71% | 22.93% | 22.94% |